Maximum daratumumab Ctrough for DARA-MD 1200 mg, DARA-MD 1800 mg, and historical data for daratumumab 16 mg/kg IV
Variable . | Dose and route of administration . | No. of patients . | Mean daratumumab Ctrough on cycle 3 day 1, µg/mL . | CV, % . |
---|---|---|---|---|
DARA-MD (PAVO) | 1200 mg SC | 5 | 543.90 | 44 |
DARA-MD (PAVO) | 1800 mg SC | 42 | 744.20 | 52 |
Daratumumab (GEN501)2 | 16 mg/kg IV | 27 | 617.17 | 51 |
Daratumumab (SIRIUS)16 | 16 mg/kg IV | 73 | 573.49 | 58 |
Variable . | Dose and route of administration . | No. of patients . | Mean daratumumab Ctrough on cycle 3 day 1, µg/mL . | CV, % . |
---|---|---|---|---|
DARA-MD (PAVO) | 1200 mg SC | 5 | 543.90 | 44 |
DARA-MD (PAVO) | 1800 mg SC | 42 | 744.20 | 52 |
Daratumumab (GEN501)2 | 16 mg/kg IV | 27 | 617.17 | 51 |
Daratumumab (SIRIUS)16 | 16 mg/kg IV | 73 | 573.49 | 58 |
CV, coefficient of variation; SC, subcutaneously.